Aashish Kabra, MD
Urology · Glenwood Springs, CONPI 1518226794
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,475 of the $50,106 with a category attached, or 70.8%. Procept Biorobotics Corporation accounts for 92.9% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $21,569, more than ten times the $1,568 reported in 2019. Among urology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $276.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$47K
- Boston Scientific$1K
- Teleflex LLC$268
- Myriad Genetic Laboratories, Inc.$244
- Neotract Inc.$228
- Astellas Pharma US Inc$164
- plus $1K from 25 others
What the payments were for
- Consulting fees$35,47571%
- Travel & lodging$9,87420%
- Food & beverage$4,7329%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 98 | $46,542 |
| Boston Scientific | 15 | $1,497 |
| Teleflex LLC | 7 | $268 |
| Myriad Genetic Laboratories, Inc. | 5 | $244 |
| Neotract Inc. | 5 | $228 |
| Astellas Pharma US Inc | 7 | $164 |
| Intuitive Surgical | 2 | $133 |
| Axonics, Inc. | 4 | $117 |
| Medtronic | 3 | $117 |
| Laborie Medical Technologies Corp. | 3 | $95 |
| Blue Earth Diagnostics | 3 | $85 |
| Endo Pharmaceuticals Inc. | 4 | $76 |
| Calyxo, Inc. | 1 | $58 |
| Dornier Medtech America, Inc | 1 | $49 |
| Histosonics, Inc. | 1 | $48 |
| Olympus America Inc. | 2 | $43 |
| Myovant Sciences Inc. | 2 | $41 |
| Fujifilm Healthcare Americas Corporation | 2 | $40 |
| Immunitybio, Inc. | 1 | $29 |
| SRS Medical Systems, Inc. | 2 | $28 |
| AbbVie | 2 | $25 |
| Angiodynamics, Inc. | 1 | $25 |
| Photocure Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Clarus Therapeutics Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Coloplast | 1 | $18 |
| Ambu Inc. | 1 | $17 |
| Urogen Pharma, Inc. | 1 | $14 |
| Progenics Pharmaceuticals, Inc. | 1 | $14 |
| Valencia Technologies Corporation | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$33,147
- AQUABEAM SYSTEM$10,953
- GENERAL KIDNEY STONE DISEASE$518
- GENERAL BPH$383
- UroLift$175
- Axonics$133
How this compares
$50,106 in reported general payments places this provider in the 90th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 74 | $65,387 |
| GemtesaVibegron | 22 | $16,551 |
| Tamsulosin Hcl | 532 | $7,908 |
| Potassium Citrate ErPotassium Citrate | 35 | $3,564 |
| Finasteride | 177 | $3,192 |
| Methenamine Hippurate | 65 | $3,109 |
| Trospium Chloride | 63 | $2,754 |
| Gentamicin Sulfate | 22 | $1,080 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 38 | $442 |
| Cephalexin | 32 | $407 |
| Solifenacin Succinate | 13 | $381 |
| Acetic Acid | 13 | $197 |
| Oxybutynin Chloride | 23 | $127 |
| Tramadol Hcl | 89 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $164 | $65,38774 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $16,55122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 225 urology providers in Colorado.
Other urology in Glenwood Springs
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
- Suzanne MerrillLone Tree$102K
- Ali SarramLone Tree$76K
- John KeferBoulder$68K
- Garrick GreearLongmont$62K
- Nicholas WestfallGrand Junction$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.